Developing psychosis and its risk states through the lens of schizotypy

Schizophrenia Bulletin

Volumn 41, Issue , 2015, Pages S396-S407

  Debbané, Martin ^a,b,c   Eliez, Stephan ^b   Badoud, Deborah ^a,b   Conus, Philippe ^d   Flückiger, Rahel ^e   Schultze Lutter, Frauke ^e  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

schizophrenia prodrome adolescence basic symptoms development

Indexed keywords

CONFERENCE PAPER; FAMILY; HIGH RISK PATIENT; HUMAN; LONGITUDINAL STUDY; MENTAL PATIENT; POSITIVE SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SCIENTIFIC LITERATURE; DISEASE PREDISPOSITION; PRODROMAL SYMPTOM; PSYCHOTIC DISORDERS;

DISEASE SUSCEPTIBILITY; HUMANS; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 84926628101     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbu176     Document Type: Conference Paper

References (76)

1. Schimmelmann BG, Walger BG, Schultze-Lutter F. The significance of at-risk symptoms for psychosis in children and adolescents. Can J Psychiatry. 2013;58:32-40
2. Gore FM, Bloem PJ, Patton GC, et al. Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet. 2011;377:2093-2102
3. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jonsson B. The economic cost of brain disorders in Europe. Eur J Neurol. 2012;19:155-162
4. Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013;70:107-120
5. Bleuler E. Dementia Praecox or the Group of Schizophrenias (J. Zinkin trans.). New York, NY: International Universities Press; 1911/1950
6. Kendler KS. Diagnostic approaches to schizotypal personality disorder: a historical perspective. Schizophr Bull. 1985;11:538-553
7. Rado S. Dynamics and classification of disordered behavior. Am J Psychiatry. 1953;140:1167-1171
8. Meehl PE. Schizotaxia, schizotypy, schizophrenia. Am Psychol. 1962;17:827-838
9. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry. 2005;10:434-449
10. Barrantes-Vidal N, Fananas L, Rosa A, Caparros B, Dolors Riba M, Obiols JE. Neurocognitive, behavioural and neurodevelopmental correlates of schizotypy clusters in adolescents from the general population. Schizophr Res.2003;61:293-302
11. Lenzenweger MF. Stability and change in personality disorder features: the Longitudinal Study of Personality Disorders. Arch Gen Psychiatry. 1999;56:1009-1015
12. Peskin M, Raine A, Gao Y, Venables PH, Mednick SA. A developmental increase in allostatic load from ages 3 to 11 years is associated with increased schizotypal personality at age 23 years. Dev Psychopathol. 2011;23:1059-1068
13. Simon AE, Velthorst E, Nieman DH, Linszen D, Umbricht D, De Haan L. Ultra high-risk state for psychosis and nontransition: a systematic review. Schizophr Res. 2011;132:8-17
14. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis pronenesspersistence-impairment model of psychotic disorder. Psychol Med. 2009;39:179-195
15. Schultze-Lutter F, Schimmelmann BG, Ruhrmann S, Michel C. A rose is a rose is a rose, but at-risk criteria differ. Psychopathology. 2013;46:75-87
16. McGlashan TH, Walsh BC, Woods SW. The Psychosis-Risk Prodrome: Handbook for Diagnosis and Follow-up. New York, NY: Oxford University Press; 2010
17. Schultze-Lutter F, Michel C, Ruhrmann S, Schimmelmann BG. Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: The Bern Epidemiological At-Risk (BEAR) Study. Schizophr Bull. 2014;40:1499-1508
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: The Association; 2013
19. Maki P, Veijola J, Jones PB, et al. Predictors of schizophrenia-a review. Br Med Bull. 2005;73-74:1-15
20. Schultze-Lutter F, Ruhrmann S, Berning J, Maier W, Klosterkotter J. Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull. 2010;36:182-191
21. Schaffner N, Schimmelmann BG, Niedersteberg A, Schultze-Lutter F. Pathways-to-care for first-episode psychotic patients-an overview of international studies. Fortschr Neurol Psychiatr. 2012;80:72-78
22. McGorry P. Preventive strategies in early psychosis: verging on reality. Br J Psychiatry Suppl. 1998;172:1-2
23. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull. 1996;22:283-303
24. Schultze-Lutter F. Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophr Bull. 2009;35:5-8
25. Parnas J, Carter JW. High-risk studies and neurodevelopmental hypothesis. In: Hafner H, ed. Risk and Protective Factors in Schizophrenia. Towards a Conceptual Model of the Disease Process. Darmstadt, Germany: Steinkopff; 2002:71-82
26. Jones PB. Risk factors for schizophrenia in childhood and youth. In: Hafner H, ed. Risk and Protective Factors in Schizophrenia. Towards a Conceptual Model of the Disease Process. Darmstadt, Germany: Steinkopff; 2002:141-162
27. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: The Association; 1994
28. Chapman LJ, Chapman JP. Scales for rating psychotic and psychotic-like experiences as continua. Schizophr Bull. 1980;6:476-489
29. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders.3rd ed., revised. Washington, DC: The Association; 1987
30. World Health Organization. International Classification of Diseases. Geneva, Switzerland: The Organization; 1994
31. Kirkbride JB, Fearon P, Morgan C, et al. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry. 2006;63:250-258
32. Simon AE, Gradel M, Cattapan-Ludewig K, et al. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome. Schizophr Res.2012;142:108-115
33. Ruhrmann S, Schultze-Lutter F, Salokangas RK, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry. 2010;67:241-251
34. Schultze-Lutter F, Klosterkotter J, Ruhrmann S. Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophr Res. 2014;154:100-106
35. Nelson B, Yuen HP, Wood SJ, et al. Long-term follow-up of a group at ultra high risk (prodromal) for psychosis: the PACE 400 study. JAMA Psychiatry. 2013;70:793-802
36. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58:158-164
37. Schultze-Lutter F, Schimmelmann BG, Klosterkotter J, Ruhrmann S. Comparing the prodrome of schizophreniaspectrum psychoses and affective disorders with and without psychotic features. Schizophr Res. 2012;138:218-222
38. Carrion RE, McLaughlin D, Goldberg TE, et al. Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry. 2013;70:1133-1142
39. Addington J, Cornblatt BA, Cadenhead KS, et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry. 2011;168:800-805
40. Yung AR, Woods SW, Ruhrmann S, et al. Whither the attenuated psychosis syndrome?. Schizophr Bull. 2012;38:1130-1134
41. Nelson MT, Seal ML, Pantelis C, Phillips LJ. Evidence of a dimensional relationship between schizotypy and schizophrenia: a systematic review. Neurosci Biobehav Rev. 2013;37:317-327
42. Blechert J, Meyer TD. Are measures of hypomanic personality, impulsive nonconformity and rigidity predictors of bipolar symptoms?. Br J Clin Psychol. 2005;44:15-27
43. Kwapil TR, Miller MB, Zinser MC, Chapman LJ, Chapman J, Eckblad M. A longitudinal study of high scorers on the hypomanic personality scale. J Abnorm Psychol. 2000;109:222-226
44. Kwapil TR, Gross GM, Silvia PJ, Barrantes-Vidal N. Prediction of psychopathology and functional impairment by positive and negative schizotypy in the Chapmans ten-year longitudinal study. J Abnorm Psychol. 2013;122:807-815
45. Kwapil TR. Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders. J Abnorm Psychol. 1998;107:558-565
46. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC. Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol. 1994;103:171-183
47. Miettunen J, Veijola J, Isohanni M, et al. Identifying schizophrenia and other psychoses with psychological scales in the general population. J Nerv Ment Dis. 2011;199:230-238
48. Bogren M, Mattisson C, Tambs K, Horstmann V, Munk-Jorgensen P, Nettelbladt P. Predictors of psychosis: a 50-year follow-up of the Lundby population. Eur Arch Psychiatry Clin Neurosci. 2010;260:113-125
49. Gooding DC, Tallent KA, Matts CW. Clinical status of at-risk individuals 5 years later: further validation of the psychometric high-risk strategy. J Abnorm Psychol. 2005;114:170-175
50. Salokangas RK, Dingemans P, Heinimaa M, et al. Prediction of psychosis in clinical high-risk patients by the Schizotypal Personality Questionnaire. Results of the EPOS project. Eur Psychiatry. 2013;28:469-475
51. Schultze-Lutter F, Klosterkotter J, Michel C, Winkler K, Ruhrmann S. Personality disorders and accentuations in atrisk persons with and without conversion to first-episode psychosis. Early Interv Psychiatry. 2012;6:389-398
52. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V. Risk factors for transition to first episode psychosis among individuals with at-risk mental states. Schizophr Res. 2004;71:227-237
53. Shah J, Eack SM, Montrose DM, et al. Multivariate prediction of emerging psychosis in adolescents at high risk for schizophrenia. Schizophr Res. 2012;141:189-196
54. Johnstone EC, Ebmeier KP, Miller P, Owens DG, Lawrie SM. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry. 2005;186:18-25
55. Carter JW, Parnas J, Cannon TD, Schulsinger F, Mednick SA. MMPI variables predictive of schizophrenia in the Copenhagen High-Risk Project: a 25-year follow-up. Acta Psychiatr Scand. 1999;99:432-440
56. Erlenmeyer-Kimling L, Cornblatt BA, Rock D, Roberts S, Bell M, West A. The New York High-Risk Project: anhedonia, attentional deviance, and psychopathology. Schizophr Bull. 1993;19:141-153
57. Nordentoft M, Thorup A, Petersen L, et al. Transition rates from schizotypal disorder to psychotic disorder for firstcontact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr Res. 2006;83:29-40
58. Wolff S. Schizoid personality in childhood and adult life. I: The vagaries of diagnostic labelling. Br J Psychiatry. 1991;159:615-620
59. Fenton WS, McGlashan TH. Risk of schizophrenia in character disordered patients. Am J Psychiatry. 1989;146:1280-1284
60. Schultze-Lutter F, Resch F, Koch E, Schimmelmann BG. Early detection of psychosis in children and adolescents-have developmental particularities been sufficiently considered?. Zeitschrift fur Kinder-und Jugendpsychiatrie und Psychotherapie 2011;39:301-311
61. Birchwood M, Fowler D, Jackson C. Early Intervention in Psychosis. Chichester, UK: John Wiley and Sons; 2002
62. McGorry PD, Killackey E, Yung A. Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry. 2008;7:148-156
63. Buchanan RW, Kreyenbuhl J, Kelly DL, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull. 2010;36:71-93
64. McGorry P. Early intervention in psychiatry: the next developmental stage. Early Interv Psychiatry. 2012;6:1-2
65. Debbane M. Schizotypy: a developmental perspective. In: Mason O, Claridge G, eds. Schizotypy: New Dimensions. Routledge. In press
66. McGlashan TH. The Chestnut Lodge follow-up study. I. Follow-up methodology and study sample. Arch Gen Psychiatry. 1984;41:573-585
67. Raine A. Schizotypal personality: neurodevelopmental and psychosocial trajectories. Annu Rev Clin Psychol. 2006;2:291-326
68. Wolff S, Townshend R, McGuire RJ, Weeks DJ. Schizoid personality in childhood and adult life. II: Adult adjustment and the continuity with schizotypal personality disorder. Br J Psychiatry.1991;159:620-629
69. Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008;65:28-37
70. Debbane M, Badoud D, Balanzin D, Eliez S. Broadly defined risk mental states during adolescence: Disorganization mediates positive schizotypal expression. Schizophr Res. 2013;147:153-156
71. Dominguez MD, Saka MC, Lieb R, Wittchen HU, van Os J. Early expression of negative/disorganized symptoms predicting psychotic experiences and subsequent clinical psychosis: a 10-year study. Am J Psychiatry. 2010;167:1075-1082
72. Ettinger U, Meyhofer I, Steffens M, Wagner M, Koutsouleris N. Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia. Front Psychiatry. 2014;5:18
73. Costa PT Jr, Terracciano A, McCrae RR. Gender differences in personality traits across cultures: robust and surprising findings. J Pers Soc Psychol. 2001;81:322-331
74. Paris J. Gender differences in personality traits and disorders. Curr Psychiatry Rep. 2004;6:71-74
75. Kelleher I, Keeley H, Corcoran P, et al. Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br J Psychiatry. 2012;201:26-32
76. Jaeschke R, Guyatt GH, Sackett DL. Users guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients?. The Evidence-Based Medicine Working Group. JAMA. 1994;271:703-707